1 of Wall Street's Favorite Stock on Our Buy List and 2 We Find Risky

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. Keeping that in mind, here is one stock where Wall Street’s excitement appears well-founded and two where analysts may be overlooking some important risks.

Two Stocks to Sell:

LeMaitre (LMAT)

Consensus Price Target: $103.67 (18.3% implied return)

Founded in 1983 and named after a pioneering vascular surgeon, LeMaitre Vascular (NASDAQGM:LMAT) develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions.

Why Do We Think Twice About LMAT?

1. Subscale operations are evident in its revenue base of $240.9 million, meaning it has fewer distribution channels than its larger rivals

At $87.62 per share, LeMaitre trades at 33.7x forward P/E. Dive into our free research report to see why there are better opportunities than LMAT.

Cogent (CCOI)

Consensus Price Target: $30.82 (26.7% implied return)

Operating a massive network spanning 20,000 miles of fiber optic cable and connecting to over 3,200 buildings worldwide, Cogent Communications (NASDAQ:CCOI) provides high-speed Internet access, private network services, and data center colocation to businesses and bandwidth-intensive organizations across 54 countries.

Why Are We Wary of CCOI?

1. Demand for its offerings was relatively low as its number of total connections has underwhelmed
2. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
3. Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution

Cogent is trading at $24.32 per share, or 10x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including CCOI in your portfolio.

One Stock to Buy:

American Superconductor (AMSC)

Consensus Price Target: $52.33 (85.6% implied return)

Founded in 1987, American Superconductor (NASDAQ:AMSC) has shifted from superconductor research to developing power systems, adapting to changing energy grid needs and naval technology requirements.

Why Are We Backing AMSC?

1. Annual revenue growth of 43.7% over the last two years was superb and indicates its market share increased during this cycle
2. Free cash flow flipped to positive over the last five years, showing the company is at an important crossroads
3. Returns on capital are increasing as management’s prior bets are starting to bear fruit

American Superconductor’s stock price of $28.20 implies a valuation ratio of 27.8x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.